Rezafungin exhibits anti-biofilm properties against fungal biofilms <i>in vitro</i>
Together, these data show that rezafungin is non-inferior to caspofungin in terms of anti-biofilm activity and displays characteristics that suggest it can control biofilms more effectively than caspofungin. Further evaluation is required to establish whether these in vitro effects translate clinically, but the data indicate an opportunity for rezafungin to be used for the clinical management of biofilm-related diseases.
Authors
- Hafsa Abduljalil
- Gordon; id_orcid 0000-0002-0932-3514 Ramage
- Riina Rautemaa-Richardson
- Kerry; id_orcid 0000-0003-3037-5295 Bartie
- Ryan Kean
- Abhijit M. Bal
- Craig Williams
Institutions
- Glasgow Caledonian University (GB)
- Royal Lancaster Infirmary (GB)
- Manchester Academic Health Science Centre (GB)
- Glasgow Royal Infirmary (GB)
- Manchester University NHS Foundation Trust (GB)
- Wythenshawe Hospital (GB)
- NIHR Manchester Biomedical Research Centre (GB)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1093/jac/dkag058
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00